4//SEC Filing
DERBYSHIRE ADAM C 4
Accession 0001209191-12-010556
CIK 0001009356other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:26 PM ET
Size
12.8 KB
Accession
0001209191-12-010556
Insider Transaction Report
Form 4
DERBYSHIRE ADAM C
EVP Finance/CFO
Transactions
- Exercise/Conversion
Common Stock
2012-02-13$4.07/sh+12,891$52,423→ 144,029 total - Sale
Common Stock
2012-02-13$50.00/sh−12,891$644,550→ 131,138 total - Exercise/Conversion
Option to Buy Common Stock
2012-02-13−12,891→ 12,600 totalExercise: $4.07Exp: 2012-07-02→ Common Stock (12,891 underlying)
Holdings
- 90,000
Option to Buy Common Stock
Exercise: $8.00Exp: 2013-05-30→ Common Stock (90,000 underlying) - 20,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (20,000 underlying) - 30,000
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]The shares covered by this Form 4 have been sold pursuant to a Rule 10b5-1 Sales Plan dated December 2, 2011, which is intended to comply with Rule 10b5-1.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeother
Related Parties
1- filerCIK 0001212669
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 5:26 PM ET
- Size
- 12.8 KB